Thermo Fisher Scientific IncTMO
Price$675.05Intrinsic value$608.8210% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $46.3B+8.1% YoYTTM through 27 Jun 2026
Net Income $7B+10.0% YoYTTM through 27 Jun 2026
Free Cash Flow $7.3BTTM through 27 Jun 2026

Margins

Current
EBITDA Margin21.7%
Operating Margin17.6%
Net Margin15.0%

Returns

13.2%ROE
6.2%ROA
7.7%ROIC

Balance Sheet Health

Debt / Equity0.80x
Current Ratio1.55x
Net Debt$38.2B
Cash & Equivalents$4.1B

Quality Metrics

Altman Z-Score3.92
Piotroski F-Score8 / 9
FCF Margin15.8%
Rule of 4019.1
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $44.6B
Diluted EPS$18.58TTM
'19'20'21'22'23'24'25
FY2025: $17.74

Dividend

$0.94Per share, FY20260.14%Yield-2.0%5-yr growth

Capital Allocation

R&D Spend$1.4B
Capex Intensity3.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.